Breaking News Instant updates and real-time market news.

2021-02-26 10:42:22 IBER Ibere Pharmaceuticals $0.00 / + (+0.00%) 10:42 02/26/21 02/26 10:42 02/26/21 10:42	Ibere Pharmaceuticals opens for trade at $10, IPO priced at $10 Ibere Pharmaceuticals priced its upsized initial public offering of 12M units at $10.00 per unit. The units are listed on the New York Stock Exchange under the ticker symbol "IBERU". Once the securities comprising the units begin separate trading, the class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols "IBER" and "IBERW," respectively. Ibere is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on opportunities in the pharmaceutical and life sciences industries. Raymond James is acting as the sole book-running manager for the offering.

2021-02-26 10:42:22

IBER

Ibere Pharmaceuticals

$0.00 / + (+0.00%)

10:42

02/26/21

02/26

10:42

02/26/21

10:42

Ibere Pharmaceuticals opens for trade at $10, IPO priced at $10

Ibere Pharmaceuticals priced its upsized initial public offering of 12M units at $10.00 per unit. The units are listed on the New York Stock Exchange under the ticker symbol "IBERU". Once the securities comprising the units begin separate trading, the class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols "IBER" and "IBERW," respectively. Ibere is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on opportunities in the pharmaceutical and life sciences industries. Raymond James is acting as the sole book-running manager for the offering.

TODAY'S FREE FLY STORIES

Hot Stocks	Rubius Therapeutics announces first patient dosed in phase 1 trial of RTX-321 » 08:10 04/12/21 04/12 08:10 04/12/21 08:10 RUBY Rubius Therapeutics $23.92 / -0.14 (-0.58%) Rubius Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events RUBY Rubius Therapeutics $23.92 / -0.14 (-0.58%) 04/09/21 Rubius Therapeutics to present initial results from Phase 1/2 trial of RTX-240 03/15/21 Rubius Therapeutics trading resumes 03/15/21 Rubius Therapeutics soars 65% to $27.05 after solid tumor trial data 03/15/21 Rubius Therapeutics trading halted, volatility trading pause RUBY Rubius Therapeutics $23.92 / -0.14 (-0.58%) 03/15/21 H.C. Wainwright Rubius Therapeutics price target raised to $40 from $28 at H.C. Wainwright 10/14/20 JPMorgan Rubius Therapeutics resumed with a Neutral at JPMorgan RUBY Rubius Therapeutics $23.92 / -0.14 (-0.58%) 02/23/21 Rubius Therapeutics reports Q4 EPS (50c), consensus (49c) 11/09/20 Rubius Therapeutics reports Q3 EPS (51c), consensus (49c) 17 Mar RUBY Rubius Therapeutics $23.92 / -0.14 (-0.58%) 03/17/21 Fly Intel: Wall Street's top stories for Wednesday 03/17/21 Fly Intel: Wall Street's top stories at midday 03/15/21 Fly Intel: Wall Street's top stories for Monday 03/15/21 Fly Intel: Wall Street's top stories at midday 05/12/21 Rubius Therapeutics, Inc
Hot Stocks	Thermo Fisher: FDA grants EUA for high-throughput COVID-19 Test » 08:10 04/12/21 04/12 08:10 04/12/21 08:10 TMO Thermo Fisher $478.87 / +7.3 (+1.55%) Thermo Fisher Scientific… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events TMO Thermo Fisher $478.87 / +7.3 (+1.55%) 03/24/21 Thermo Fisher to offer integrated COVID-19 testing to U.S. school districts 03/24/21 Thermo Fisher announces launch of in-air SARS-CoV-2 surveillance solution 03/10/21 Thermo Fisher investing over $600M to expand bioprocessing production 03/08/21 Chembio Diagnostics appoints David Bespalko to board of directors TMO Thermo Fisher $478.87 / +7.3 (+1.55%) 03/29/21 UBS Thermo Fisher price target lowered to $560 from $588 at UBS 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc 03/02/21 Barclays Thermo Fisher initiated with an Overweight at Barclays TMO Thermo Fisher $478.87 / +7.3 (+1.55%) 02/01/21 Thermo Fisher sees FY21 EPS $21.62, consensus $20.74 02/01/21 Thermo Fisher reports Q4 adjusted EPS $7.09, consensus $6.56 12/01/20 Thermo Fisher raises FY20 adjusted EPS view to $19.17, consensus $18.34 10/21/20 Thermo Fisher sees FY20 EPS $18.27, consensus $15.92 TMO Thermo Fisher $478.87 / +7.3 (+1.55%) 02/08/21 Quidel weighs combining with Qiagen, Bloomberg reports TMO Thermo Fisher $478.87 / +7.3 (+1.55%) 02/01/21 Fly Intel: Pre-market Movers 12/01/20 Fly Intel: Wall Street's top stories for Tuesday 10/21/20 Fly Intel: Pre-market Movers 05/24/21 Global Healthcare Virtual Conference 2021 04/29/21 Thermo Fisher - TMO 05/19/21 Thermo Fisher Scientific Inc.
Hot Stocks	Tattooed Chef launches new plant-based pizzas » 08:10 04/12/21 04/12 08:10 04/12/21 08:10 TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) Tattooed Chef announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) 03/10/21 Tattooed Chef launches six plant-based products at Target stores 01/14/21 Tattooed Chef announces redemption of public warrants 12/08/20 Tattooed Chef expands product range with meal alternatives TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) 12/03/20 Jefferies Tattooed Chef initiated with a Hold at Jefferies 11/17/20 Roth Capital Tattooed Chef initiated with a Buy at Roth Capital TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) 03/10/21 Tattooed Chef backs FY21 revenue view $222M, consenus $224M 03/10/21 Tattooed Chef reports Q4 EPS 56c, consensus 3c TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) 11/20/20 Tattooed Chef tells Bloomberg short report claims 'false' and 'misleading' 11/19/20 Kerrisdale Capital short Tattooed Chef, sees 'investors left holding the bag' 11/19/20 Tattooed Chef named as short by Kerrisdale Capital TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) 03/10/21 Fly Intel: After-Hours Movers 12/08/20 Fly Intel: After-Hours Movers TTCF Tattooed Chef $19.15 / -0.05 (-0.26%) 04/08/21 Tattooed Chef put volume heavy and directionally bearish 03/10/21 Tattooed Chef options imply 16.8% move in share price post-earnings 02/04/21 Largest borrow rate increases among liquid names 02/01/21 Largest borrow rate increases among liquid names
Hot Stocks	Morphic presents preclinical data from avb8 integrin program at AACR meeting » 08:09 04/12/21 04/12 08:09 04/12/21 08:09 MORF Morphic $59.10 / -1.94 (-3.18%) Morphic Therapeutic… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly MORF Morphic $59.10 / -1.94 (-3.18%) 03/01/21 Morphic Holding Inc trading resumes 03/01/21 Morphic Holding Inc trading halted, volatility trading pause 03/01/21 Morphic Holding reports interim results from Phase 1 trial of MORF-057 01/05/21 Morphic Therapeutic expands R&D collaboration with Janssen MORF Morphic $59.10 / -1.94 (-3.18%) 03/03/21 SVB Leerink Protagonist Therapeutics price target raised to $41 from $30 at SVB Leerink 03/01/21 Wells Fargo Morphic Holding price target raised to $103 from $40 at Wells Fargo 02/02/21 RBC Capital Morphic Holding price target raised to $50 from $35 at RBC Capital 10/26/20 RBC Capital Morphic Holding initiated with an Outperform at RBC Capital MORF Morphic $59.10 / -1.94 (-3.18%) 03/01/21 Morphic Holding reports 2020 EPS ($1.47), consensus ($1.41) 11/09/20 Morphic Holding reports Q3 EPS 17c, consensus (48c) 03 Mar MORF Morphic $59.10 / -1.94 (-3.18%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: Pre-market Movers 03/01/21 Fly Intel: After-Hours Movers
Hot Stocks	Mirum Pharmaceuticals and Vivet in pact for Vivet's gene therapy » 08:08 04/12/21 04/12 08:08 04/12/21 08:08 MIRM Mirum Pharmaceuticals $18.34 / -0.76 (-3.98%) Mirum Pharmaceuticals and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events MIRM Mirum Pharmaceuticals $18.34 / -0.76 (-3.98%) 03/29/21 Mirum Pharmaceuticals announces FDA acceptance of maralixibat NDA 03/08/21 Mirum Pharmaceuticals CFO buys 1.6K shares of common stock 02/01/21 Mirum completes rolling NDA submission for maralixibat in Alagille 12/09/20 Mirum Pharmaceuticals, Oberland announce up to $210M funding arrangement MIRM Mirum Pharmaceuticals $18.34 / -0.76 (-3.98%) 03/29/21 Piper Sandler Piper says Mirum approval for Alagille syndrome 'in the bag' 02/08/21 SVB Leerink Mirum Pharmaceuticals initiated with an Outperform at SVB Leerink 02/01/21 Piper Sandler Piper says FDA 'very unlikely' to require AdCom for Mirum's maralixibat in ALGS 12/09/20 Piper Sandler Mirum Pharmaceuticals investor day highlights pipeline advances, says Piper MIRM Mirum Pharmaceuticals $18.34 / -0.76 (-3.98%) 03/09/21 Mirum Pharmaceuticals reports Q4 EPS ($1.43), consensus (72c) 11/12/20 Mirum Pharmaceuticals reports Q3 EPS (86c), consensus (97c) 15 Dec MIRM Mirum Pharmaceuticals $18.34 / -0.76 (-3.98%) 12/15/20 Fly Intel: Wall Street's top stories at midday 12/15/20 Fly Intel: Pre-market Movers 09/29/21 PDUFA Date for Maralixibat

Hot Stocks	FLIR Systems awarded up to $20.5M DARPA contract » 08:08 04/12/21 04/12 08:08 04/12/21 08:08 FLIR FLIR Systems $57.69 / + (+0.00%) FLIR Systems announced it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options FLIR FLIR Systems $57.69 / + (+0.00%) 04/01/21 Teledyne clears Canada, Germany antitrust reviews for acquisition of FLIR Systems 01/26/21 FLIR gets $30.1M contract boost from US Army for sustainment efforts on programs 01/13/21 FLIR Systems announces $23M in awards from U.S. CBP 01/04/21 FLIR Systems jumps 22% to $53.75 after agreeing to be acquired by Teledyne FLIR FLIR Systems $57.69 / + (+0.00%) 01/07/21 Berenberg FLIR Systems downgraded to Hold from Buy at Berenberg 01/05/21 Canaccord FLIR Systems downgraded to Hold from Buy at Canaccord 01/05/21 William Blair FLIR Systems downgraded to Market Perform from Outperform at William Blair 01/05/21 Needham Teledyne price target raised to $395 from $365 at Needham FLIR FLIR Systems $57.69 / + (+0.00%) 02/25/21 FLIR Systems reports Q4 EPS 78cc, consensus 62c 10/30/20 FLIR Systems raises FY20 adj. EPS view to $2.30-$2.35 from $2.10-$2.30 10/30/20 FLIR Systems reports Q3 adj. EPS 64c, consensus 55c FLIR FLIR Systems $57.69 / + (+0.00%) 01/04/21 Fly Intel: Wall Street's top stories for Monday 01/04/21 Fly Intel: Wall Street's top stories at midday 01/04/21 Fly Intel: Pre-market Movers FLIR FLIR Systems $57.69 / + (+0.00%) 01/15/21 Largest borrow rate increases among liquid names 01/04/21 Early notable gainers among liquid option names on January 4th
Hot Stocks	Lakeland Financial launches Lack City Bank Digital » 08:08 04/12/21 04/12 08:08 04/12/21 08:08 LKFN Lakeland Financial $68.69 / -0.2 (-0.29%) Lake City Bank announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Events LKFN Lakeland Financial $68.69 / -0.2 (-0.29%) 02/11/21 Lakeland Financial director Smith sells over $650K in stock 01/13/21 Lakeland Financial raises quarterly dividend 13% to 34c per share LKFN Lakeland Financial $68.69 / -0.2 (-0.29%) 01/25/21 Lakeland Financial reports Q4 EPS 97c, consensus 80c 10/26/20 Lakeland Financial reports Q3 EPS 89c, consensus 71c 04/13/21 Lakeland Financial Corporation
Hot Stocks	REE Automotive signs collaboration agreement with Magna » 08:07 04/12/21 04/12 08:07 04/12/21 08:07 VCVC 10X Capital Venture Acquisition $10.06 / -0.03 (-0.30%) REE Automotive, an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News On The Fly Options VCVC 10X Capital Venture Acquisition $10.06 / -0.03 (-0.30%) 03/15/21 REE Automotive teases announcement coming March 16 02/03/21 10X Capital Venture Acquisition Corporation (Class A Stock) trading resumes 02/03/21 REE Automotive to become public in $3.1B 10X Capital Venture Acquisition merger 02/03/21 10X Capital Venture Acquisition Corporation (Class A Stock) trading halted, news pending VCVC 10X Capital Venture Acquisition $10.06 / -0.03 (-0.30%) 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 02/03/21 Fly Intel: Pre-market Movers 11/29/20 Opening Day: Russian online retailer raises $990M in U.S. IPO VCVC 10X Capital Venture Acquisition $10.06 / -0.03 (-0.30%) 02/10/21 Seven new option listings and three option delistings on February 10th
Initiation	Sun Country Airlines initiated with an Equal Weight at Morgan Stanley » 08:07 04/12/21 04/12 08:07 04/12/21 08:07 SNCY Sun Country Airlines $38.18 / -0.08 (-0.21%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate Periodicals On The Fly SNCY Sun Country Airlines $38.18 / -0.08 (-0.21%) 04/11/21 Goldman Sachs Sun Country Airlines initiated with a Buy at Goldman Sachs 17 Mar SNCY Sun Country Airlines $38.18 / -0.08 (-0.21%) 03/16/21 Sun Country Airlines to price IPO at $24/shr, above $21-$23 range, Bloomerg says SNCY Sun Country Airlines $38.18 / -0.08 (-0.21%) 03/20/21 Opening Day: China's Tuya raised $915M in U.S. IPO
Hot Stocks	BIO-key announces new fingerprint scanner hardware additions » 08:06 04/12/21 04/12 08:06 04/12/21 08:06 BKYI BIO-key $3.58 / -0.09 (-2.45%) BIO-key International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options BKYI BIO-key $3.58 / -0.09 (-2.45%) 04/07/21 BIO-key adds Kristel Communication to Channel Alliance Partner Program 04/05/21 BIO-key announces $1.2M contract extension for fingerprint biometric security 03/31/21 International Defense Ministry continue expansion of BIO-key biometric solutions 03/23/21 BIO-key begins biometric technology deployments for ID projects in Africa BKYI BIO-key $3.58 / -0.09 (-2.45%) 03/26/21 Maxim BIO-key upgraded to Buy from Hold at Maxim 03/26/21 Maxim BIO-key upgraded to Buy from Hold at Maxim BKYI BIO-key $3.58 / -0.09 (-2.45%) 03/25/21 BIO-key sees 2021 revenue $8M-$12M, one est. $7.5M 03/25/21 BIO-key reports Q4 EPS (18c), one est. (16c) 01/27/21 BIO-key's IDaaS platform selected by Southeastern Illinois College 11/12/20 BIO-key reports Q3 EPS (6c), one est. (1c) BKYI BIO-key $3.58 / -0.09 (-2.45%) 02/18/21 Fourteen new option listings and one option delisting on February 18th

Hot Stocks	Jounce Therapeutics appoints Dmitri Wiederschain as Chief Scientific Officer » 08:06 04/12/21 04/12 08:06 04/12/21 08:06 JNCE Jounce Therapeutics $9.76 / -0.65 (-6.24%) , SNY Sanofi $50.80 / +0.43 (+0.85%) Jounce Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events JNCE SNY JNCE Jounce Therapeutics $9.76 / -0.65 (-6.24%) 04/11/21 Jounce Therapeutics presents preclinical data from JTX-8064/LILRB2 Program 02/25/21 Jounce Therapeutics sees cash, cash equivalents sufficient into 2Q23 02/12/21 Jounce Therapeutics appoints Luisa Salter-Cid to board of directors 01/29/21 Adage Capital reports 6.95% passive stake in Jounce Therapeutics SNY Sanofi $50.80 / +0.43 (+0.85%) 07:21 Today C4XD enters licensing agreement with Sanofi for oral IL-17A inhibitor program 04/09/21 Sanofi acquires Tidal Therapeutics for $160M upfront payment 04/09/21 Sanofi says interim late-breaking data validate not-alpha profile of THOR-707 03/31/21 Sanofi announces FDA approved Sarclisa+carfilzomib in RRMM JNCE SNY JNCE Jounce Therapeutics $9.76 / -0.65 (-6.24%) 03/14/21 Piper Sandler Jounce Therapeutics initiated with an Overweight at Piper Sandler 02/26/21 H.C. Wainwright Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright 12/04/20 H.C. Wainwright Jounce Therapeutics assumed with a Buy at H.C. Wainwright 11/10/20 Roth Capital Jounce Therapeutics price target lowered to $15 from $28 at Roth Capital SNY Sanofi $50.80 / +0.43 (+0.85%) 04/06/21 Barclays Sanofi price target raised to EUR 85 from EUR 80 at Barclays 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 02/10/21 Morgan Stanley Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley 02/05/21 Piper Sandler Piper reiterates Overweight on Kymera after Sanofi capital markets day JNCE SNY JNCE Jounce Therapeutics $9.76 / -0.65 (-6.24%) 02/25/21 Jounce Therapeutics reports Q4 EPS 86c, consensus 22c 11/06/20 Jounce Therapeutics reports Q3 EPS (73c), consensus (47c) SNY Sanofi $50.80 / +0.43 (+0.85%) 02/05/21 Sanofi reports Q4 business EPS EUR 1.22, flat vs. last year 10/29/20 Sanofi reports Q3 business EPS EUR 1.83, up 0.5% from last year 10 Mar SNY SNY Sanofi $50.80 / +0.43 (+0.85%) 03/15/21 BioNTech recruits Novartis, Sanofi to boost vaccine production, WSJ reports 02/15/21 CEO says Sanofi mRNA vaccine won't be ready this year, Bloomberg reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 02/11/21 Amgen loses appeal to revive PCSK9 antibody patent suit, Bloomberg reports JNCE SNY JNCE Jounce Therapeutics $9.76 / -0.65 (-6.24%) 03/09/21 Fly Intel: After-Hours Movers SNY Sanofi $50.80 / +0.43 (+0.85%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 04/28/21 Sanofi - SNY 05/18/21 PDUFA Date for Avalglucosidase Alfa
Hot Stocks	Osisko Gold to acquire additional royalties in Nevada, Idaho for $26M » 08:06 04/12/21 04/12 08:06 04/12/21 08:06 OR Osisko Gold $12.11 / +0.065 (+0.54%) Through a subsidiary,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings OR Osisko Gold $12.11 / +0.065 (+0.54%) 04/08/21 Osisko Gold releases ESG report 02/16/21 Osisko Gold receives approval for Canadian Malartic Underground construction 01/20/21 Osisko Gold appoints Candace MacGibbon to board of directors 01/13/21 Osisko Gold appoints Heather Taylor to VP, investor relations OR Osisko Gold $12.11 / +0.065 (+0.54%) 04/06/21 Scotiabank Osisko Gold price target raised to C$28.50 from C$27.50 at Scotiabank 02/26/21 National Bank Osisko Gold price target lowered to C$23 from C$23.50 at National Bank 02/25/21 BMO Capital Osisko Gold price target lowered to C$20 from C$21 at BMO Capital 02/12/21 Scotiabank Osisko Gold price target raised to C$27.50 from C$25 at Scotiabank OR Osisko Gold $12.11 / +0.065 (+0.54%) 08:03 Today Osisko Gold reports Q1 preliminary revenue C$66.9M, one est. C$69.36M 01/13/21 Osisko Gold reports Q4 preliminary revenues C$64.5M 10/20/20 Osisko Gold reports preliminary Q3 revenues C$55.7M, consensus C$59.25M
Hot Stocks	VBI Vaccines announces data, next steps from VBI-2601 high-dose cohort » 08:05 04/12/21 04/12 08:05 04/12/21 08:05 VBIV VBI Vaccines $2.80 / -0.08 (-2.78%) VBI Vaccines announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Events VBIV VBI Vaccines $2.80 / -0.08 (-2.78%) 03/10/21 CEPI and VBI Vaccines collaborate to advance vaccine candidates against COVID-19 03/09/21 VBI Vaccines begins enrollment of Phase 1/2 clinical study of VBI-2902 03/09/21 VBI Vaccines begins enrollment in prophylactic COVID-19 vaccine candidate 02/02/21 FDA accepts VBI Vaccines BLA filing for its antigen prophylactic Hep B vaccine VBIV VBI Vaccines $2.80 / -0.08 (-2.78%) 02/25/21 Jefferies VBI Vaccines initiated with a Buy at Jefferies 08/27/20 Raymond James VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James 08/27/20 Oppenheimer VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer 08/26/20 Raymond James VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James VBIV VBI Vaccines $2.80 / -0.08 (-2.78%) 03/02/21 VBI Vaccines reports Q4 revenue $200,000, consensus $410,000 22 Apr VBIV VBI Vaccines $2.80 / -0.08 (-2.78%) 02/10/21 Scientists working on shot that could protect against Covid-19, others, NYT says 11/30/21 PDUFA Date for
Hot Stocks	Gemini Therapeutics appoints Samuel Barone, M.D., as Chief Medical Officer » 08:05 04/12/21 04/12 08:05 04/12/21 08:05 GMTX Gemini Therapeutics $13.27 / -0.735 (-5.25%) Gemini Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options GMTX Gemini Therapeutics $13.27 / -0.735 (-5.25%) 02/10/21 Gemini Therapeutics completes enrollment in Phase 2a Trial of GEM103 02/09/21 Gemini Therapeutics appoints Brian Piekos as CFO 02/08/21 Gemini Therapeutics completes business combination with FSDC, debuts on Nasdaq GMTX Gemini Therapeutics $13.27 / -0.735 (-5.25%) 04/08/21 SVB Leerink SVB Leerink bullish on Gemini Therapeutics, initiates with an Outperform 04/08/21 SVB Leerink Gemini Therapeutics initiated with an Outperform at SVB Leerink 03/03/21 Jefferies Gemini Therapeutics initiated with a Buy at Jefferies 03/02/21 Goldman Sachs Gemini Therapeutics initiated with a Buy at Goldman Sachs GMTX Gemini Therapeutics $13.27 / -0.735 (-5.25%) 02/09/21 Five new option listings and two option delistings on February 9th
Hot Stocks	Leap Therapeutics, Flagship Biosciences announce partnership » 08:05 04/12/21 04/12 08:05 04/12/21 08:05 LPTX Leap Therapeutics $1.80 / -0.03 (-1.64%) Flagship Biosciences and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly LPTX Leap Therapeutics $1.80 / -0.03 (-1.64%) 04/01/21 Leap Therapeutics completes enrollment in first-line cohort of DKN-01 study 03/22/21 Leap Therapeutics presents clinical data from Phase 2 trial of DKN-01 12/22/20 Leap Therapeutics announces publication of mechanism of action data for DKN-01 11/09/20 Leap Therapeutics presents DKN-01 data at AACR conference LPTX Leap Therapeutics $1.80 / -0.03 (-1.64%) 03/22/21 Piper Sandler Leap data suggest DKN-01 likely providing clinical benefit, says Piper Sandler 01/29/21 Baird Leap Therapeutics assumed at Outperform at Baird 06/29/20 Piper Sandler Leap Therapeutics initiated with an Overweight at Piper Sandler LPTX Leap Therapeutics $1.80 / -0.03 (-1.64%) 03/12/21 Leap Therapeutics reports Q4 EPS (9c), consensus (9c) 11/12/20 Leap Therapeutics reports Q3 EPS (9c), consensus (13c) 18 Jun LPTX Leap Therapeutics $1.80 / -0.03 (-1.64%) 03/22/21 Fly Intel: Pre-market Movers

General news	U.S. equity futures » 08:05 04/12/21 04/12 08:05 04/12/21 08:05 $ECON Economic Data / + U.S. equity futures are… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<
Hot Stocks	Nuance trading halted, news pending 08:04 04/12/21 04/12 08:04 04/12/21 08:04 NUAN Nuance $45.59 / +0.38 (+0.84%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NUAN Nuance $45.59 / +0.38 (+0.84%) 04/11/21 Fly Intel: Top five weekend stock stories 02/08/21 Nuance says FY21 guidance update reflects government Coding contract extension 02/08/21 Nuance acquires Saykara, terms not disclosed 11/30/20 Nuance CTO sells 59.5K shares of common stock NUAN Nuance $45.59 / +0.38 (+0.84%) 07:36 Today B. Riley Nuance possible takeout positive for peer LivePerson, says B. Riley 07:29 Today Wedbush Nuance deal would be 'trophy' for Microsoft, says Wedbush 03/10/21 Wedbush Nuance added to Best Ideas List at Wedbush 03/08/21 Morgan Stanley Software industry rating raised to Attractive from In-Line at Morgan Stanley NUAN Nuance $45.59 / +0.38 (+0.84%) 02/08/21 Nuance raises FY21 revenue view to $1.34B-$1.38B from $1.33B-$1.37B 02/08/21 Nuance sees Q2 EPS 14c-18c, consensus 18c 02/08/21 Nuance reports Q1 adjusted EPS 20c, consensus 18c 11/18/20 Nuance says FY21 guidance reflects continuing Enterprise revenue growth NUAN Nuance $45.59 / +0.38 (+0.84%) 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says NUAN Nuance $45.59 / +0.38 (+0.84%) 03/08/21 Microsoft, Salesforce rise as analysts get more bullish on software sector 02/08/21 Fly Intel: After-Hours Movers 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Fly Intel: Wall Street's top stories at midday NUAN Nuance $45.59 / +0.38 (+0.84%) 04/07/21 Nuance call volume above normal and directionally bullish 03/23/21 Nuance call buyer realizes 9% same-day gains 02/08/21 Nuance options imply 10.5% move in share price post-earnings
Earnings	Osisko Gold reports Q1 preliminary revenue C$66.9M, one est. C$69.36M » 08:03 04/12/21 04/12 08:03 04/12/21 08:03 OR Osisko Gold $12.11 / +0.065 (+0.54%) Osisko received… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings OR Osisko Gold $12.11 / +0.065 (+0.54%) 04/08/21 Osisko Gold releases ESG report 02/16/21 Osisko Gold receives approval for Canadian Malartic Underground construction 01/20/21 Osisko Gold appoints Candace MacGibbon to board of directors 01/13/21 Osisko Gold appoints Heather Taylor to VP, investor relations OR Osisko Gold $12.11 / +0.065 (+0.54%) 04/06/21 Scotiabank Osisko Gold price target raised to C$28.50 from C$27.50 at Scotiabank 02/26/21 National Bank Osisko Gold price target lowered to C$23 from C$23.50 at National Bank 02/25/21 BMO Capital Osisko Gold price target lowered to C$20 from C$21 at BMO Capital 02/12/21 Scotiabank Osisko Gold price target raised to C$27.50 from C$25 at Scotiabank OR Osisko Gold $12.11 / +0.065 (+0.54%) 01/13/21 Osisko Gold reports Q4 preliminary revenues C$64.5M 10/20/20 Osisko Gold reports preliminary Q3 revenues C$55.7M, consensus C$59.25M
Hot Stocks	GT Biopharma reports interim results from GTB-3550 TriKE Phase I/II trial » 08:03 04/12/21 04/12 08:03 04/12/21 08:03 GTBP GT Biopharma $10.39 / +1.79 (+20.81%) GT Biopharma announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Events GTBP GT Biopharma $10.39 / +1.79 (+20.81%) 04/08/21 GT Biopharma enrolls tenth patient in TriKE Phase I/II clinical trial 03/17/21 GT Biopharma updates interim results of GTB-3550 clinical trial 03/08/21 GT Biopharma announces preclinical results for ROR1 TriKE product candidate 03/04/21 GT Biopharma adds second site in Phase 1/2 trial of cancer candidate GTB-3550 GTBP GT Biopharma $10.39 / +1.79 (+20.81%) 03/17/21 Roth Capital GT Biopharma initiated with a Buy at Roth Capital 11 Feb 04/13/21 GT Biopharma 04/14/21 GT Biopharma 04/15/21 GT Biopharma
Hot Stocks	AgroFresh Solutions appoints Clinton Lewis Jr. as CEO » 08:03 04/12/21 04/12 08:03 04/12/21 08:03 AGFS AgroFresh Solutions $2.15 / -0.06 (-2.71%) , PFE Pfizer $36.60 / +0.64 (+1.78%) , ZTS Zoetis $159.91 / -0.12 (-0.07%) AgroFresh Solutions… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AGFS PFE ZTS AGFS AgroFresh Solutions $2.15 / -0.06 (-2.71%) 03/29/21 AgroFresh Solutions reachs patent infringement settlement with Decco, UPL 03/16/21 AgroFresh Solutions says Camposol to adopt VitaFresh Botanicals coatings 02/24/21 AgroFresh Solutions launches plant-based coatings under VitaFresh brand PFE Pfizer $36.60 / +0.64 (+1.78%) 06:59 Today Myovant Sciences, Pfizer: First patient dosed in Phase 3 SERENE study 04/09/21 Pfizer, BioNTech seek expansion of vaccine EUA to include 12-15 year olds 04/08/21 Celcuity announces gedatolisib licensing agreement with Pfizer 04/07/21 U.K. offers Pfizer, Moderna vaccine to those under 30 with risk conditions ZTS Zoetis $159.91 / -0.12 (-0.07%) 02/22/21 Zoetis receives European Commission marketing authorization for Solensia 12/09/20 Zoetis raises quarterly dividend by 25% to 25c per share 11/12/20 Zoetis receives European Commissionmarketing authorization for Librela AGFS PFE ZTS AGFS AgroFresh Solutions $2.15 / -0.06 (-2.71%) 12/16/20 BMO Capital AgroFresh Solutions initiated with a Market Perform at BMO Capital PFE Pfizer $36.60 / +0.64 (+1.78%) 04/09/21 Pfizer to host conference call 04/06/21 RBC Capital Pfizer transferred with a Sector Perform at RBC Capital 03/17/21 Mizuho AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance ZTS Zoetis $159.91 / -0.12 (-0.07%) 03/09/21 Stifel Zoetis 'oversold,' among 'best long-term ideas,' says Stifel 03/08/21 Raymond James Zoetis upgraded to Outperform from Market Perform at Raymond James 03/08/21 Raymond James Zoetis upgraded to Outperform from Market Perform at Raymond James 03/08/21 BofA Zoetis upgraded to Buy from Neutral at BofA AGFS PFE ZTS AGFS AgroFresh Solutions $2.15 / -0.06 (-2.71%) 03/10/21 AgroFresh Solutions reports Q4 EPS (18c), consensus 5c 11/05/20 AgroFresh reports Q3 EPS (52c), consensus 8c PFE Pfizer $36.60 / +0.64 (+1.78%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open ZTS Zoetis $159.91 / -0.12 (-0.07%) 02/16/21 Zoetis sees FY21 EPS $4.36-$4.46 , consensus $4.26Zoetis 02/16/21 Zoetis reports Q4 EPS 91c, consensus 87c 11/05/20 Zoetis sees FY20 EPS $3.76-$3.81 , consensus $3.64 11/05/20 Zoetis reports Q3 EPS $1.10, consensus 91c PFE PFE Pfizer $36.60 / +0.64 (+1.78%) 04/09/21 EU seeks contract for 1.8B COVID-19 doses with Pfizer, BioNTech, Reuters reports 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/05/21 Pfizer working on new deal to supply COVID-19 vaccines to Israel, Reuters says 04/05/21 Walgreens to change vaccine scheduling to comply with guidelines, NYT reports PFE PFE Pfizer $36.60 / +0.64 (+1.78%) 04/10/21 Opening Day: Phone maker UTime soars in public debut 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/01/21 Fly Intel: Wall Street's top stories for Thursday 05/04/21 Pfizer - PFE 05/06/21 Zoetis - ZTS 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 04/22/21 Pfizer Inc 05/20/21 Zoetis Inc. PFE PFE Pfizer $36.60 / +0.64 (+1.78%) 04/09/21 Pfizer call volume above normal and directionally bullish 04/09/21 Early notable gainers among liquid option names on April 9th 03/15/21 Pfizer call volume above normal and directionally bullish 03/04/21 Pfizer call volume above normal and directionally bullish

Recommendations	Carlisle price target raised to $188 from $175 at Oppenheimer » 08:02 04/12/21 04/12 08:02 04/12/21 08:02 CSL Carlisle $171.68 / +1.72 (+1.01%) Oppenheimer analyst Bryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CSL Carlisle $171.68 / +1.72 (+1.01%) 02/12/21 Carlisle names Kelly P. Kamienski as Controller 02/02/21 Carlisle announces additional buyback of 5M shares of common stock CSL Carlisle $171.68 / +1.72 (+1.01%) 05:50 Today Longbow Carlisle downgraded to Neutral from Buy at Longbow 03/25/21 Fly Intel: Top five analyst upgrades 03/25/21 Loop Capital Carlisle upgraded to Buy from Hold at Loop Capital 01/26/21 Longbow Carlisle price target raised to $160 from $150 at Longbow CSL Carlisle $171.68 / +1.72 (+1.01%) 02/04/21 Carlisle reports Q4 EPS $1.57, consensus $1.16 10/20/20 Carlisle reports Q3 EPS $1.87, consensus $1.68 04/22/21 Carlisle - CSL 05/05/21 Carlisle Companies
Initiation	SBA Communications initiated with a Buy at Jefferies » 08:01 04/12/21 04/12 08:01 04/12/21 08:01 SBAC SBA Communications $275.49 / -4.15 (-1.48%) Jefferies analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events SBAC SBA Communications $275.49 / -4.15 (-1.48%) 02/22/21 Dish signs master lease agreement with SBA Communications 02/02/21 PG&E unit sells rights to 700 towers to SBA Communications for $973M 01/24/21 Fly Intel: Top five weekend stock stories SBAC SBA Communications $275.49 / -4.15 (-1.48%) 03/25/21 KeyBanc SBA Communications upgraded to Overweight from Sector Weight at KeyBanc 03/18/21 Wolfe Research SBA Communications initiated with an Outperform at Wolfe Research 03/05/21 Raymond James SBA Communications upgraded to Strong Buy from Outperform at Raymond James 03/05/21 Raymond James SBA Communications upgraded to Strong Buy from Outperform at Raymond James SBAC SBA Communications $275.49 / -4.15 (-1.48%) 02/22/21 SBA Communications sees FY21 AFFO $10-$10.41, consensus $10.12 02/22/21 SBA Communications reports Q4 AFFO $2.49, consensus $2.44 11/02/20 SBA Communications raises FY20 AFFO view to $9.27-$9.50 from $8.94-$9.33 11/02/20 SBA Communications reports Q3 AFFO $2.38, consensus $2.32 SBAC SBA Communications $275.49 / -4.15 (-1.48%) 01/23/21 SBA, Equinix among names to buy in year of digital infrastructure, Barron's says 05/24/21 Global Technology, Media & Communications Virtual Conference 04/26/21 SBA Communications - SBAC 05/13/21 SBA Communications Corporation
Initiation	Crown Castle initiated with a Buy at Jefferies » 08:00 04/12/21 04/12 08:00 04/12/21 08:00 CCI Crown Castle $175.26 / -0.51 (-0.29%) Jefferies analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CCI Crown Castle $175.26 / -0.51 (-0.29%) 03/10/21 Crown Castle CFO Schlanger sells over $750K in shares 03/02/21 Crown Castle chairman buys 7.8K shares of common stock 02/26/21 Crown Castle CCO Kavanagh sells nearly 4,000 common shares 12/18/20 Crown Castle releases 2019 corporate sustainability report CCI Crown Castle $175.26 / -0.51 (-0.29%) 03/25/21 KeyBanc Crown Castle upgraded to Overweight from Sector Weight at KeyBanc 03/19/21 Wolfe Research Crown Castle initiated with a Peer Perform at Wolfe Research 01/14/21 Citi Crown Castle upgraded to Buy from Neutral at Citi 01/11/21 BofA BofA US 1 List changes CCI Crown Castle $175.26 / -0.51 (-0.29%) 01/27/21 Crown Castle,Verizon expand relationship with long term 5G small cell commitment 01/27/21 Crown Castle backs FY21 AFFO view $6.64-$6.74, consensus $6.70 01/27/21 Crown Castle reports Q4 AFFO $2.33, consensus $1.65 01/27/21 Notable companies reporting after market close CCI Crown Castle $175.26 / -0.51 (-0.29%) 01/23/21 SBA, Equinix among names to buy in year of digital infrastructure, Barron's says CCI Crown Castle $175.26 / -0.51 (-0.29%) 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades 05/24/21 Global Technology, Media & Communications Virtual Conference 04/22/21 Crown Castle - CCI 05/21/21 Crown Castle International Corp
Initiation	American Tower initiated with a Buy at Jefferies » 08:00 04/12/21 04/12 08:00 04/12/21 08:00 AMT American Tower $239.06 / -0.765 (-0.32%) Jefferies analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events AMT American Tower $239.06 / -0.765 (-0.32%) 03/15/21 American Tower, Dish in master lease pact for up to 20,000 sites 01/13/21 American Tower enters pact with Telefonica to acquire Telxius Towers for $9.4B 11/05/20 American Tower to acquire InSite Wireless for total consideration of $3.5B AMT American Tower $239.06 / -0.765 (-0.32%) 03/25/21 KeyBanc American Tower upgraded to Overweight from Sector Weight at KeyBanc 03/18/21 Wolfe Research American Tower initiated with an Outperform at Wolfe Research 03/08/21 RBC Capital American Tower price target lowered to $250 from $275 at RBC Capital 02/26/21 Cowen American Tower price target lowered to $324 from $334 at Cowen AMT American Tower $239.06 / -0.765 (-0.32%) 02/25/21 American Tower reports Q4 EPS 82c, consensus $1,27 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 American Tower raises midpoint of FY20 property revenue by $165M 05/24/21 Global Technology, Media & Communications Virtual Conference 04/29/21 American Tower - AMT
Options	Gap call buyer realizes 60% same-day gains » 08:00 04/12/21 04/12 08:00 04/12/21 08:00 GPS Gap $32.43 / +1.02 (+3.25%) Notable profits for the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GPS Gap $32.43 / +1.02 (+3.25%) 03/25/21 Gap agrees to sell Janie and Jack brand to Go Global Retail 03/25/21 Gap agrees to sell Janie and Jack brand to Go Global Retail 03/04/21 Gap recorded $56M impairment charge in Q4 related to Intermix 03/04/21 Gap reports Q4 Old Navy Global SSS up 7% y/y GPS Gap $32.43 / +1.02 (+3.25%) 03/15/21 Wells Fargo Gap price target raised to $40 from $32 at Wells Fargo 03/09/21 MKM Partners Gap price target raised to $29 from $21 at MKM Partners 03/08/21 Barclays Gap price target raised to $32 from $27 at Barclays 03/08/21 Deutsche Bank Gap price target raised to $31 from $26 at Deutsche Bank GPS Gap $32.43 / +1.02 (+3.25%) 03/04/21 Gap sees FY21 EPS $1.20-$1.35, consensus $1.28 03/04/21 Gap reports Q4 EPS 61c, consensus 18c 03/04/21 Notable companies reporting after market close 11/24/20 Gap reports Q3 Old Navy SSS up 17% y/y GPS Gap $32.43 / +1.02 (+3.25%) 03/08/21 Gap mulling options, including possible sale, for China business, Bloomberg says 03/08/21 Gap said to consider sale of China business, Bloomberg says 03/05/21 Gap CEO sees 'peacocking effect' as people emerge from Covid, WSJ reports 02/28/21 Macy's, Gap letting customers buy now, pay later, WSJ reports GPS Gap $32.43 / +1.02 (+3.25%) 03/04/21 Fly Intel: After-Hours Movers 02/16/21 American Express downgrade among today's top calls on Wall Street 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 11/25/20 Fly Intel: Wall Street's top stories at midday 05/11/21 Gap Inc. GPS Gap $32.43 / +1.02 (+3.25%) 03/10/21 Gap call volume above normal and directionally bullish 03/05/21 Early notable gainers among liquid option names on March 5th 02/02/21 Gap call volume above normal and directionally bullish 11/27/20 Notable open interest changes for November 27th

Events

Earnings calls, analyst events, roadshows and more

INCY
Today at 08:30

Incyte - INCY Conference Calls
Today at 08:30

Technology;Media;Telecom Industry Meetings
APHA
Today at 09:00

Aphria - APHA Conference Calls
Today at 09:00

Infrastructure Industry Meetings
BBVA
Today at 09:00

European Banking/Financials Industry Meetings
ZLAB
Today at 10:00

Zai Lab - ZLAB Conference Calls
OTCM
Today at 10:00

OTC Markets Group Inc. Firm Sponsored Meetings

Virtual Meeting
Today at 10:00

Energy Industry Meetings
Today at 10:00

Retail/Softlines & Dept Stores Industry Meetings
CRDF
Today at 11:00

Cardiff Oncology - CRDF Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Ibere Pharmaceuticals opens for trade at $10, IPO priced at $10

TODAY'S FREE FLY STORIES

Get Full Fly Access